Compositions and methods for regulating NK cell activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8637258
APP PUB NO 20100291110A1
SERIAL NO

12813040

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method of producing an antibody that cross-reacts with multiple KIR2DL polypeptides and neutralizes the inhibitory activity of such polypeptides.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INNATE PHARMA S A121 ANCIEN CHEMIN DE CASSIS MARSEILLE 13009

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andre, Pascale Marseilles, FR 31 339
Della, Chiesa Mariella Genoa, IT 9 86
Gauthier, Laurent Marseilles, FR 93 598
Moretta, Alessandro Genoa, IT 32 304
Padkjaer, Soren Berg Vaerlose, DK 4 35
Reumert, Wagtmann Peter Andreas Nicolai Rungsted Kyst, DK 4 23

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 28, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00